Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Latest FDA Denosumab Decisions Offer Mixed Verdicts
Amneal-mAbxience Enjoy Approval But Alvotech-Dr Reddy’s Get CRL
Jan 02 2026
•
By
Dave Wallace
The FDA outcomes have been positive and negative for two pairs of denosumab biosimilars
(Shutterstock)
More from Biosimilars
More from Products